AIM
TARO

Aigen Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Aigen Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-341
Closed -$19K – 1152
2020
Q3 		$19K Sell
341
-6,181
-95% -$385K ﹤0.01% 790
2020
Q2 		$434K Buy
6,522
+3,334
+105% +$224K 0.06% 511
2020
Q1 		$195K Buy
3,188
+649
+26% +$48.1K 0.03% 716
2019
Q4 		$223K Buy
+2,539
New +$214K 0.04% 519

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aigen Investment Management's TARO Position: Q4 2020 in Review

Aigen Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2020, closing a stake of 341 shares — an estimated $19K sold.

Aigen Investment Management first reported a position in TARO in Q4 2019 and held it in 4 quarters. The position peaked at $434K in Q2 2020. 84 funds tracked by Wall St. Rank hold TARO as of Q4 2020.

  • Aigen Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 341 Taro Pharmaceutical Industries Ltd. shares in Q4 2020, an estimated $19K.
  • Aigen Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $434K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.